scholarly article | Q13442814 |
P2093 | author name string | Karen M Ottemann | |
J Elliot Carter | |||
Annah S Rolig | |||
Ethan Ahler | |||
Cynthia Cech | |||
P2860 | cites work | A core gut microbiome in obese and lean twins | Q24649648 |
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Induction of intestinal Th17 cells by segmented filamentous bacteria | Q28131638 | ||
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases | Q28131810 | ||
Induction of colonic regulatory T cells by indigenous Clostridium species | Q29547701 | ||
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 | ||
A microbial symbiosis factor prevents intestinal inflammatory disease | Q29614263 | ||
Helicobacter pylori and gastrointestinal tract adenocarcinomas | Q29618635 | ||
Molecular analysis of the bacterial microbiota in the human stomach | Q33231429 | ||
High-density universal 16S rRNA microarray analysis reveals broader diversity than typical clone library when sampling the environment | Q33276592 | ||
Comparative analysis of human gut microbiota by barcoded pyrosequencing | Q33356063 | ||
Spatial distribution and stability of the eight microbial species of the altered schaedler flora in the mouse gastrointestinal tract | Q33707348 | ||
Structure of the human gastric bacterial community in relation to Helicobacter pylori status | Q33711853 | ||
Deep-sea oil plume enriches indigenous oil-degrading bacteria | Q34132984 | ||
Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis | Q34187114 | ||
Helicobacter pylori and gastric cancer: factors that modulate disease risk | Q34189885 | ||
Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. | Q34427123 | ||
Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pylori-induced gastric pathology | Q34947026 | ||
Coinfection with Enterohepatic Helicobacter species can ameliorate or promote Helicobacter pylori-induced gastric pathology in C57BL/6 mice | Q35273158 | ||
Peripheral education of the immune system by colonic commensal microbiota. | Q35341308 | ||
Bacterial chemotaxis modulates host cell apoptosis to establish a T-helper cell, type 17 (Th17)-dominant immune response in Helicobacter pylori infection | Q35621260 | ||
Chronic Helicobacter pylori infection does not significantly alter the microbiota of the murine stomach | Q35641978 | ||
DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection | Q35780308 | ||
Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia | Q36050870 | ||
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice | Q36087089 | ||
Helicobacter pylori in health and disease | Q36816611 | ||
The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases | Q37014743 | ||
Helicobacter pylori: gastric cancer and beyond | Q37760037 | ||
Associations and physiological interactions of indigenous microorganisms and gastrointestinal epithelia | Q39920803 | ||
The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases | Q41203280 | ||
Lactobacillus reuteri promotes Helicobacter hepaticus-associated typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice. | Q45966062 | ||
An animal model of gastric ulcer due to bacterial gastritis in mice | Q70943837 | ||
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain | Q73212144 | ||
Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype | Q74298184 | ||
A reproducible scoring system for quantification of histologic lesions of inflammatory disease in mouse gastric epithelium | Q79910467 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
Helicobacter pylori | Q180556 | ||
P304 | page(s) | 1382-1389 | |
P577 | publication date | 2013-02-19 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | The degree of Helicobacter pylori-triggered inflammation is manipulated by preinfection host microbiota | |
P478 | volume | 81 |
Q46360679 | A Summary of the 2016 James W. Freston Conference of the American Gastroenterological Association: Intestinal Metaplasia in the Esophagus and Stomach: Origins, Differences, Similarities and Significance |
Q38839739 | A microbiota-centric view of diseases of the upper gastrointestinal tract |
Q35698838 | Allergies, Helicobacter pylori and the continental enigmas |
Q44410046 | Anti-inflammatory properties of gastric-derived Lactobacillus plantarum XB7 in the context of Helicobacter pylori infection. |
Q27023485 | At the Bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer |
Q36221371 | Characterization of Gastric Microbiota in Twins |
Q37591498 | Chronic inflammation and oxidative stress: the smoking gun for Helicobacter pylori-induced gastric cancer? |
Q26775617 | Effect of Helicobacter pylori Infection on the Composition of Gastric Microbiota in the Development of Gastric Cancer |
Q37378692 | Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients |
Q35026959 | Friend and foe: factors influencing the movement of the bacterium Helicobacter pylori along the parasitism-mutualism continuum |
Q33621825 | Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis |
Q34109460 | Gastric microbiome and gastric cancer |
Q37716976 | Gastrointestinal malignancy and the microbiome. |
Q35549642 | H. pylori and its modulation of gastrointestinal microbiota |
Q90674606 | Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects |
Q38192615 | Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs |
Q56243474 | Helicobacter pylori is associated with increased risk of serrated colonic polyps: Analysis of serrated polyp risk factors |
Q36116464 | Helicobacter pylori, Cancer, and the Gastric Microbiota |
Q55317441 | Helicobacter pylori-infected C57BL/6 mice with different gastrointestinal microbiota have contrasting gastric pathology, microbial and host immune responses. |
Q38604850 | High Spatial and Temporal Variations of Microbial Community along the Southern Catfish Gastrointestinal Tract: Insights into Dynamic Food Digestion |
Q28085629 | Human Microbiome: When a Friend Becomes an Enemy |
Q35923800 | Imbalance of Gastrointestinal Microbiota in the Pathogenesis of Helicobacter pylori-Associated Diseases |
Q64915338 | Modification of the Gastric Mucosal Microbiota by a Strain-Specific Helicobacter pylori Oncoprotein and Carcinogenic Histologic Phenotype. |
Q28655590 | Replenishing our defensive microbes |
Q38194659 | Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract--beyond the era of Helicobacter pylori |
Q35052635 | Role of childhood infection in the sequelae of H. pylori disease |
Q35410354 | Streptococcus mitis induces conversion of Helicobacter pylori to coccoid cells during co-culture in vitro |
Q34780560 | Survival in hostile territory: the microbiota of the stomach |
Q38653409 | The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors |
Q36108718 | The Role of the Microbiome in Gastrointestinal Cancer. |
Q47156406 | The bacterial virulence factor CagA induces microbial dysbiosis that contributes to excessive epithelial cell proliferation in the Drosophila gut. |
Q34129365 | The gastric microbial community, Helicobacter pylori colonization, and disease. |
Q42370919 | The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer. |
Q27004050 | The human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases? |
Q34959399 | The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis |
Q35153341 | Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia |
Search more.